PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1957 January; 50(1): 1–12.
PMCID: PMC1888987

Symposium on Anti-Tumour Agents

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • HADDOW A, TIMMIS GM. Myleran in chronic myeloid leukaemia; chemical constitution and biological action. Lancet. 1953 Jan 31;264(6753):207–208. [PubMed]
  • LARIONOV LF. Some biological and clinical results from the investigations of the chloroethylamines as anti-tumour drugs. Br J Cancer. 1956 Mar;10(1):26–32. [PMC free article] [PubMed]
  • LARIONOV LF, SHKODINSKAJA EN, TROOSHEIKINA VI, KHOKHLOV AS, VASINA OS, NOVIKOVA MA. Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine). Lancet. 1955 Jul 23;269(6882):169–171. [PubMed]
  • MATTHEWS WB. A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases. Lancet. 1950 May 13;1(6611):896–899. [PubMed]
  • ROSS WC, WARWICK GP. Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature. 1955 Aug 13;176(4476):298–299. [PubMed]
  • STOCK CC, BUCKLEY S, SUGIURA K, RHOADS CP. A comparison of the retardation of Sarcoma 180 by SK 1424, 3-Bis (beta-chloroethyl) aminomethyl-4-methoxymethyl-5-hydroxy-6-methyl-pyridine with that by HN2, Methylbis (beta-chloroethyl) amine. Cancer Res. 1951 Jun;11(6):432–436. [PubMed]
  • HEBBORN P, DANIELLI JF. Selectivity of enzyme-activated nitrogen mustards. Nature. 1956 Jan 7;177(4497):25–27. [PubMed]
  • BOYLAND E. Synergism in cancer therapy. Proc R Soc Med. 1956 Nov;49(11):877–879. [PubMed]
  • ELLISON RR, KARNOFSKY DA, STERNBERG SS, MURPHY ML, BURCHENAL JH. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease. Cancer. 1954 Jul;7(4):801–814. [PubMed]
  • HITCHINGS GH, FALCO EA, VANDERWERFF H, RUSSELL PB, ELION GB. Antagonists of nucleic acid derivatives. VII. 2, 4-Diaminopyrimidines. J Biol Chem. 1952 Nov;199(1):43–56. [PubMed]
  • MURPHY ML, ELLISON RR, KARNOFSKY DA, BURCHENAL JH. Clinical effects of the dichloro and monochlorophenyl analogues of diamino pyrimidine: antagonists of folic acid. J Clin Invest. 1954 Oct;33(10):1388–1396. [PMC free article] [PubMed]
  • PHILIPS FS, STERNBERG SS, HAMILTON S, CLARKE DA. The toxic effects of 6-mercaptopurine and related compounds. Ann N Y Acad Sci. 1954 Dec 6;60(2):283–296. [PubMed]
  • WEISBERGER AS, SUHRLAND LG. Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia. Blood. 1956 Jan;11(1):19–30. [PubMed]
  • WHITE LP, SHIMKIN MB. Effects of DL-ethionine in six patients with neoplastic disease. Cancer. 1954 Sep;7(5):867–872. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press